Please login to the form below

Not currently logged in
Email:
Password:

ProPharma selects new CEO and president

Dawn Sherman takes up the roles effective 14 May

ProPharma Group has appointed a new chief executive officer and president in the form of Dawn Sherman.

Sherman brings extensive international strategy and experience to the group following multiple executive leadership positions.

Most recently, Sherman was president of EnvisionRxOptions, a role where she was responsible for the pharmacy benefit management and technology company lines of business.

She has also held the role of chief operating officer for Teva Pharmaceuticals, where her focus included strategy and innovation for patient solutions, commercial effectiveness, market access, business insights and market intelligence.

Sherman said: “It is an honour to join ProPharma Group and the great people that have contributed to the company’s success.

“I am incredibly excited about the many opportunities that lie ahead for this dynamic, growing business.

Sherman succeeds Jeff Hargroves, founder and CEO of ProPharma group, who will continue to be an active member of the board.

1st May 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics